Donna Kerrigan

3.0k citations
41 papers · 2.7k · h-index 27

Impact in

  • Toxicology top 0.1%
    • Bioactive Compounds and Antitumor Agents
  • Oncology top 2%
    • Lung Cancer Research Studies
    • Neutropenia and Cancer Infections
    • Drug Transport and Resistance Mechanisms

Papers in

    • Cancer therapeutics and mechanisms 30
    • DNA and Nucleic Acid Chemistry 20
    • DNA Repair Mechanisms 12
    • Lung Cancer Research Studies 8
    • Metal complexes synthesis and properties 3
    • Neutropenia and Cancer Infections 3

Donna Kerrigan

41 papers receiving 2.6k citations

Peers

Donna Kerrigan
Comparison fields: 5 of 89
  • Toxicology 523
  • Oncology 1.1k
  • Molecular Biology 2.4k
  • Organic Chemistry 417
  • Pharmacology 174
Replace K M Tewey with:
K M Tewey United States
Joseph M. Covey United States
Y H Hsiang United States
Yoji Ikegami Japan
Jan M. Woynarowski United States
Michael I. Walton United Kingdom
Elisabetta Leo United Kingdom
M.D. Feese United States
Linda H. Malkas United States
Hongliang Zhang China
Donna Kerrigan relative to K M Tewey United States K M Tewey's profile →
Citations per field
00.5×1.5×
K M Tewey · 1×
Citations per year

Countries citing papers authored by Donna Kerrigan

Since Specialization
Citations

This map shows the geographic impact of Donna Kerrigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Kerrigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Kerrigan more than expected).

Fields of papers citing papers by Donna Kerrigan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Kerrigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Kerrigan. The network helps show where Donna Kerrigan may publish in the future.

Co-authors

The 25 scholars most cited alongside Donna Kerrigan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Donna Kerrigan Line = papers co-authored together Donna Kerrigan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Differential requirement of DNA replication for the cytotoxicity of DNA topoisomerase I and II inhibitors in Chinese hamster DC3F cells.
1989334
2 1991178
3
Altered DNA topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors.
1986152
4 1986133
5
Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression.
1991130
6 1990124
7 1987121
8 1992100
9
Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells.
198798
10
Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors.
198697
11
Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.
198294
12 198281
13 198278
14 198277
15 199172
16
DNA strand breaks produced by etoposide (VP-16,213) in sensitive and resistant human breast tumor cells: implications for the mechanism of action.
198868
17 198268
18
Topoisomerase II-mediated DNA damage produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity.
198866
19 198365
20
Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells.
198864

About Donna Kerrigan

Donna Kerrigan is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Toxicology and Pharmacology, having authored 41 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (30 papers), DNA and Nucleic Acid Chemistry (20 papers), DNA Repair Mechanisms (12 papers), Synthesis and Biological Evaluation (9 papers), Lung Cancer Research Studies (8 papers), Bioactive Compounds and Antitumor Agents (7 papers), Metal complexes synthesis and properties (3 papers) and Neutropenia and Cancer Infections (3 papers). The work is most often cited by research in Toxicology (523 citations), Oncology (1.1k citations), Molecular Biology (2.4k citations), Organic Chemistry (417 citations) and Pharmacology (174 citations). Donna Kerrigan has collaborated with scholars based in United States, Malaysia and France. Frequent co-authors include Yves Pommier, Leonard A. Zwelling, Kurt W. Kohn, Joseph M. Covey, Connie Holm, Ronald E. Schwartz, Richard Bertrand, Michael R. Mattern, Stephen Michaels and Judith Markovits. Their work appears in journals such as Biochemical Pharmacology, Biochemical and Biophysical Research Communications, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact